Your browser is no longer supported. Please, upgrade your browser.
COLL Collegium Pharmaceutical, Inc. daily Stock Chart
COLL [NASD]
Collegium Pharmaceutical, Inc.
Index- P/E- EPS (ttm)-0.34 Insider Own2.40% Shs Outstand33.08M Perf Week2.68%
Market Cap785.65M Forward P/E13.34 EPS next Y1.78 Insider Trans-35.32% Shs Float32.42M Perf Month12.19%
Income-11.40M PEG- EPS next Q-0.10 Inst Own99.79% Short Float7.43% Perf Quarter23.63%
Sales295.90M P/S2.66 EPS this Y52.00% Inst Trans5.35% Short Ratio4.07 Perf Half Y101.27%
Book/sh2.52 P/B9.42 EPS next Y337.00% ROA-3.80% Target Price31.50 Perf Year53.13%
Cash/sh4.65 P/C5.11 EPS next 5Y0.55% ROE-13.10% 52W Range10.01 - 25.59 Perf YTD15.40%
Dividend- P/FCF16.68 EPS past 5Y-7.60% ROI-20.10% 52W High-11.49% Beta0.87
Dividend %- Quick Ratio1.20 Sales past 5Y- Gross Margin41.10% 52W Low126.27% ATR1.45
Employees266 Current Ratio1.20 Sales Q/Q3.80% Oper. Margin-3.50% RSI (14)51.09 Volatility4.84% 5.98%
OptionableYes Debt/Eq0.14 EPS Q/Q63.50% Profit Margin-3.90% Rel Volume1.38 Prev Close23.75
ShortableYes LT Debt/Eq0.10 EarningsFeb 27 AMC Payout- Avg Volume592.77K Price22.65
Recom1.70 SMA201.96% SMA504.48% SMA20049.19% Volume569,318 Change-4.63%
Feb-19-20Resumed Jefferies Buy $43
Oct-30-19Reiterated Needham Buy $33 → $25
May-03-19Resumed H.C. Wainwright Buy $23
Apr-12-19Resumed Janney Buy $29
Mar-20-19Initiated SunTrust Hold $22
Jan-16-19Reiterated Needham Buy $35 → $33
Mar-08-18Reiterated H.C. Wainwright Buy $21 → $33
Feb-07-18Reiterated Needham Buy $28 → $35
Dec-05-17Reiterated Needham Buy $25 → $28
Sep-11-17Initiated H.C. Wainwright Buy $21
May-11-17Reiterated Needham Buy $28 → $25
Sep-13-16Initiated Gabelli & Co Buy $25
Jun-01-15Initiated Piper Jaffray Overweight $26
Jun-01-15Initiated Needham Buy $28
Jun-01-15Initiated Jefferies Buy $20
Feb-20-20 12:31PM  Earnings Preview: Collegium Pharmaceutical (COLL) Q4 Earnings Expected to Decline Zacks
Feb-13-20 04:01PM  Collegium Announces Closing of the Nucynta Franchise Acquisition GlobeNewswire
Feb-10-20 07:15PM  Collegium Pharmaceutical, Inc. Prices $125.0 Million Convertible Senior Notes Offering GlobeNewswire -15.05%
07:20AM  Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering GlobeNewswire
Feb-08-20 07:04AM  What Kind Of Share Price Volatility Should You Expect For Collegium Pharmaceutical, Inc. (NASDAQ:COLL)? Simply Wall St.
Feb-07-20 07:32AM  The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns Benzinga +25.37%
Feb-06-20 04:01PM  Collegium to Acquire U.S. Rights to Nucynta Franchise GlobeNewswire
Jan-31-20 05:00PM  Biohaven Appoints Michael Heffernan To Board Of Directors PR Newswire
Jan-21-20 08:41AM  Prospects Appear Bright for Small Drug Industry in 2020 Zacks -7.90%
Jan-14-20 11:50AM  Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now? Zacks
Jan-09-20 08:39AM  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results Benzinga
Jan-08-20 08:12AM  The Daily Biotech Pulse: Verastem In-Licenses Chughai's Tumor Drug, Midatech Surges On Positive Study Results Benzinga +11.04%
Jan-07-20 04:05PM  Collegium Provides 2020 Financial Guidance GlobeNewswire
Dec-13-19 11:32AM  These Hedge Funds Cashed Out Of Collegium Pharmaceutical Inc (COLL) Too Early Insider Monkey
Dec-10-19 05:43PM  Edited Transcript of COLL earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Dec-06-19 02:39PM  Hedge Funds Love Unisys Corporation (UIS) Way More Than These 4 Stocks Insider Monkey
Nov-26-19 08:01AM  Collegium to Participate in Upcoming Investor Conferences GlobeNewswire
Nov-08-19 08:14AM  The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut Benzinga +10.89%
08:00AM  Collegium to Participate in Upcoming Investor Conference GlobeNewswire
Nov-06-19 06:25PM  Collegium Pharmaceutical (COLL) Reports Q3 Loss, Misses Revenue Estimates Zacks
04:01PM  Collegium Reports Third Quarter 2019 Financial Results GlobeNewswire
02:16PM  Were Hedge Funds Right About Souring On Collegium Pharmaceutical (COLL)? Insider Monkey
Oct-30-19 10:34AM  Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Oct-23-19 08:00AM  Collegium to Host Conference Call to Discuss Third Quarter 2019 Financial Results and Provide Corporate Update GlobeNewswire
Oct-19-19 10:02AM  Collegium Pharmaceutical (NASDAQ:COLL) Has Debt But No Earnings; Should You Worry? Simply Wall St.
Sep-26-19 04:08PM  Edited Transcript of COLL earnings conference call or presentation 7-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Sep-25-19 08:00AM  Collegium to Participate in Upcoming Investor Conference GlobeNewswire
Sep-23-19 06:00AM  The Opioid Crisis Has Upended Pain Management. Whats Next for the Industry. Barrons.com
Sep-03-19 04:01PM  Collegium to Participate in Upcoming Investor Conferences GlobeNewswire -6.04%
Aug-29-19 04:01PM  Collegium Announces Scientific Presentations at PAINWeek 2019 National Conference GlobeNewswire
Aug-08-19 11:24PM  Assertio Therapeutics, Inc (ASRT) Q2 2019 Earnings Call Transcript Motley Fool
12:23AM  Collegium Pharmaceutical, Inc. (COLL) Q2 2019 Earnings Call Transcript Motley Fool
Aug-07-19 06:35PM  Collegium Pharmaceutical (COLL) Q2 Earnings Surpass Estimates Zacks
Jul-31-19 10:36AM  Earnings Preview: Collegium Pharmaceutical (COLL) Q2 Earnings Expected to Decline Zacks
Jul-24-19 04:01PM  Collegium to Host Conference Call to Discuss Second Quarter 2019 Financial Results and Provide Corporate Update GlobeNewswire
Jul-23-19 12:19PM  Imagine Owning Collegium Pharmaceutical (NASDAQ:COLL) And Wondering If The 48% Share Price Slide Is Justified Simply Wall St.
Jun-28-19 05:03PM  Edited Transcript of COLL earnings conference call or presentation 8-May-19 8:30pm GMT Thomson Reuters StreetEvents
Jun-19-19 10:41AM  Hedge Funds Have Never Been This Bullish On Collegium Pharmaceutical Inc (COLL) Insider Monkey +6.52%
May-29-19 08:00AM  Collegium to Present at Upcoming Investor Conferences GlobeNewswire
May-09-19 10:03PM  Collegium Pharmaceutical, Inc. (COLL) Q1 2019 Earnings Call Transcript Motley Fool +5.05%
01:53PM  Were Hedge Funds Right About Dumping Collegium Pharmaceutical Inc (COLL) ? Insider Monkey
11:24AM  Assertio Therapeutics, Inc (ASRT) Q1 2019 Earnings Call Transcript Motley Fool
May-08-19 05:45PM  Collegium Pharmaceutical (COLL) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:37PM  Collegium Pharmaceutical: 1Q Earnings Snapshot Associated Press
04:01PM  Collegium Reports First Quarter 2019 Financial Results GlobeNewswire
May-06-19 11:54AM  Assertio Therapeutics (ASRT) to Post Q1 Earnings: What's Up? Zacks +5.15%
May-05-19 09:19AM  2 Big Biotech Stock Upgrades: Can They Reach These Targets? Motley Fool
May-01-19 10:33AM  Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Apr-30-19 04:01PM  Collegium to Participate in Upcoming Investor Conferences GlobeNewswire -7.20%
Apr-24-19 04:01PM  Collegium to Host Conference Call to Discuss First Quarter 2019 Financial Results and Provide Corporate Update GlobeNewswire
Apr-02-19 08:00AM  Collegium Appoints Richard Malamut, M.D., as Chief Medical Officer GlobeNewswire
Apr-01-19 08:00AM  Collegium to Present at Upcoming Investor Conferences GlobeNewswire
Mar-31-19 09:45AM  Read This Before Buying Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Simply Wall St.
Mar-25-19 09:00AM  Collegium Pharmaceutical (COLL) Upgraded to Buy: What Does It Mean for the Stock? Zacks
Mar-06-19 11:49PM  Assertio Therapeutics, Inc (ASRT) Q4 2018 Earnings Conference Call Transcript Motley Fool
Mar-04-19 01:46AM  Edited Transcript of COLL earnings conference call or presentation 27-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-27-19 07:14PM  Collegium Pharmaceutical Inc (COLL) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:01PM  Collegium Reports Fourth-Quarter and Full-Year 2018 Financial Results GlobeNewswire
Feb-20-19 10:31AM  Collegium Pharmaceutical (COLL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Feb-15-19 09:30AM  ASRT or COLL: Which Is the Better Value Stock Right Now? Zacks +6.48%
Feb-13-19 08:40AM  Collegium to Host Conference Call to Discuss Fourth Quarter 2018 Financial Results and Provide Corporate Update GlobeNewswire
Feb-12-19 02:03PM  Breakeven On The Horizon For Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Simply Wall St.
Jan-30-19 09:30AM  ASRT vs. COLL: Which Stock Should Value Investors Buy Now? Zacks
Jan-17-19 07:20AM  Report: Developing Opportunities within Enterprise Products Partners, Antero Midstream Partners LP, Integrated Device Technology, Collegium Pharmaceutical, GAIN Capital, and United Technologies Future Expectations, Projections Moving into 2019 GlobeNewswire
Jan-14-19 09:30AM  ASRT vs. COLL: Which Stock Should Value Investors Buy Now? Zacks
Jan-07-19 08:00AM  Collegium Provides Full-Year 2019 Financial Guidance GlobeNewswire -19.55%
Dec-19-18 11:43PM  Do Hedge Funds Love Collegium Pharmaceutical Inc (COLL)? Insider Monkey -8.21%
06:53PM  Edited Transcript of COLL earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Dec-11-18 02:31PM  How Financially Strong Is Collegium Pharmaceutical, Inc. (NASDAQ:COLL)? Simply Wall St.
Nov-26-18 04:44PM  Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Are Hedge Funds Right About This Stock? Insider Monkey
Nov-12-18 07:24AM  Collegium to Present at Upcoming Investor Conferences GlobeNewswire
Nov-08-18 07:25PM  Collegium Pharmaceutical (COLL) Reports Q3 Loss, Lags Revenue Estimates Zacks
06:21PM  Collegium Pharmaceutical: 3Q Earnings Snapshot Associated Press
04:05PM  Collegium Reports Third Quarter Financial Results GlobeNewswire
08:04AM  Collegium Pharmaceutical Q3 Earnings Preview Benzinga
Nov-01-18 11:28AM  Collegium Pharmaceutical (COLL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-29-18 08:00AM  Collegium Announces Publication of Data on Oral Abuse Potential of Xtampza ER GlobeNewswire
Oct-18-18 08:00AM  Report: Exploring Fundamental Drivers Behind Continental Building Products, Hornbeck Offshore Services, Digi International, Triple-S Management, Collegium Pharmaceutical, and Cardiovascular New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-17-18 08:30AM  Collegium to Host Conference Call to Discuss Third Quarter 2018 Financial Results and Provide Corporate Update GlobeNewswire
Sep-28-18 02:16PM  Collegium to Present at Upcoming Investor Conference GlobeNewswire
Sep-04-18 10:01AM  Collegium Announces Scientific Presentations at PAINWeek 2018 Meeting GlobeNewswire
Aug-24-18 07:30AM  Report: Exploring Fundamental Drivers Behind Fiesta Restaurant Group, Emerge Energy Services LP, Collegium Pharmaceutical, Cutera, Resources Connection, and Spark Therapeutics New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Aug-23-18 11:45PM  Edited Transcript of COLL earnings conference call or presentation 8-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-08-18 07:30PM  Collegium Pharmaceutical (COLL) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:01PM  Collegium Reports Second Quarter Financial Results and Provides Corporate Update GlobeNewswire
02:30PM  Collegium Pharmaceutical, Inc. to Host Earnings Call ACCESSWIRE
10:16AM  Q2 Earnings Preview Collegium Pharmaceutical Benzinga
Jul-31-18 07:10AM  Complimentary Technical Snapshots on Akorn and Three More Generic Drugs Stocks ACCESSWIRE
Jul-20-18 01:06PM  Collegium to Host Conference Call to Discuss Second Quarter 2018 Financial Results and Provide Corporate Update GlobeNewswire
Jul-10-18 07:30AM  Collegium Announces Promotion of Scott Dreyer to CCO GlobeNewswire
Jun-28-18 07:50AM  Free Research Reports on Catalent and Three More Generic Drugs Stocks ACCESSWIRE
Jun-26-18 02:55PM  Is Collegium Pharmaceutical Inc (NASDAQ:COLL) A Financially Sound Company? Simply Wall St.
Jun-18-18 07:40AM  New Research: Key Drivers of Growth for Outfront Media, Enel Chile, Banc of California, Northern Dynasty Minerals, Collegium Pharmaceutical, and Petroleo Brasileiro S.A. - Petrobras Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jun-12-18 04:10PM  Cantor Fitzgerald Out Bullish On Collegium As 'Leading Company' In Pain Management Benzinga +7.13%
Jun-04-18 04:01PM  Collegium Announces CEO Succession GlobeNewswire
May-30-18 04:01PM  Collegium to Present at Upcoming Investor Conferences GlobeNewswire
May-14-18 09:52PM  Edited Transcript of COLL earnings conference call or presentation 9-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-11-18 07:00AM  Free Daily Technical Summary Reports on Horizon Pharma and Three More Generic Drugs Stocks ACCESSWIRE
May-10-18 05:40PM  Why Depomed Inc.'s Shares Soared 23.2% Higher Motley Fool +7.73%
May-09-18 04:14PM  Collegium Pharmaceutical: 1Q Earnings Snapshot Associated Press
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes various products for patients suffering from pain. It provides DETERx platform technology that is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods of abuse and misuse, including chewing, crushing, heating, and injecting. The company offers Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for opioid medication. Furhter, it offers Nucynta ER, an extended release formulation of tapentadol for the management of pain severe enough to require daily, around-the-clock, long term opioid treatment, such as neuropathic pain related to diabetic peripheral neuropathy in adults; and Nucynta IR, an immediate release formulation of tapentadol that is indicated for the management of moderate to severe acute pain in adults. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Heffernan Michael ThomasDirectorJan 21Option Exercise5.73275,4631,578,403402,086Jan 22 04:29 PM
Heffernan Michael ThomasDirectorJan 21Sale21.93295,2876,476,863106,799Jan 22 04:29 PM
Dreyer ScottEVP & Chief Commercial OfficerJan 14Sale23.871,32131,53235,716Jan 16 04:12 PM
Fleming Alison BChief Technology OfficerNov 08Option Exercise5.7325,000143,25098,556Nov 13 04:32 PM
Hirsch DavidDirectorNov 08Sale19.3325,000483,25017,117Nov 13 04:33 PM
Fleming Alison BChief Technology OfficerNov 08Sale19.4425,000486,00073,556Nov 13 04:32 PM
Ciaffoni JosephPresident and CEONov 07Option Exercise8.2264,821532,829242,276Nov 08 04:11 PM
Ciaffoni JosephPresident and CEONov 07Sale18.7764,8211,216,774177,455Nov 08 04:11 PM
Hirsch DavidDirectorAug 29Option Exercise9.3319,853185,22864,223Sep 03 06:16 PM
Hirsch DavidDirectorAug 29Sale11.6522,106257,53542,117Sep 03 06:16 PM
Heffernan Michael ThomasDirectorJul 15Sale11.2625,000281,500132,069Jul 17 04:22 PM
Dreyer ScottEVP & Chief Commercial OfficerJul 11Sale12.312,85735,17037,739Jul 12 04:08 PM
Heffernan Michael ThomasDirectorJun 17Sale11.3725,000284,246157,069Jun 19 06:05 PM
Ciaffoni JosephPresident and CEOJun 03Sale11.597,43686,183180,222Jun 04 04:17 PM
Ciaffoni JosephPresident and CEOMay 31Sale11.525,85167,404190,755Jun 04 04:17 PM
Heffernan Michael ThomasDirectorMay 15Sale12.8425,000321,042182,069May 17 04:04 PM
Heffernan Michael ThomasDirectorApr 15Sale15.0925,000377,366202,362Apr 17 04:24 PM
Heffernan Michael ThomasDirectorMar 15Sale17.1725,000429,250227,362Mar 19 05:36 PM